Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1α induction

Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer

(2012) Xiaozhu Zhang et al.   International Journal of Medical Sciences

Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell

(2010) Xian-Run Luo et al.   MOLECULAR BIOLOGY REPORTS

Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy

(2009) Ryan J.O. Dowling et al.   BIODRUGS

Akt-dependent and -independent mechanisms of mTOR regulation in cancer

(2009) Regan M. Memmott et al.   CELLULAR SIGNALLING

Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer

(2009) Yu-Qing Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Insulin-like Growth Factor-I Receptor Signaling Pathway Induces Resistance to the Apoptotic Activities of SCH66336 (Lonafarnib) through Akt/Mammalian Target of Rapamycin-Mediated Increases in Survivin Expression

(2008) S. H. Oh et al.   CLINICAL CANCER RESEARCH

Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer

(2007) Duygu Derin et al.   LUNG CANCER